Parasites of the genus Leishmania cause a variety of devastating and often fatal diseases in
humans and domestic animals worldwide. The need for new therapeutic strategies is urgent …

Although there are available treatments for cutaneous leishmaniasis (CL), the drugs used
are far from ideal, toxic, and costly, in addition to the challenge faced by the development of …

Leishmania infections are global, occurring in 98 countries and all World Health
Organization (WHO) regions with 600 million to 1 billion people at risk of infection. Visceral …

Tegumentary leishmaniasis (TL) includes cutaneous (CL) and mucosal (ML) leishmaniasis;
despite being endemic in southern Europe, it is often underdiagnosed and underreported …

Leishmaniasis is a complex disease. Any change in weather conditions affects the humans'
social and agricultural expansion and, consequently, the parasite's life cycle in terms of …

Visceral leishmaniasis is a major, life-threatening parasitic disease that still remains a
serious public health problem in Ethiopia. Understanding the epidemiological, clinical, and …

Visceral leishmaniasis is a vector-borne, protozoan disease with severe public health
implications. Following the successful implementation of an elimination programme in South …

Neglected tropical diseases (NTDs) are a group of disease conditions that affect the world's
poorest people in low-and middle-income countries. NTDs are associated with negative …

Leishmaniasis, one of the most overlooked tropical diseases, is a life-threatening illness
caused by the parasite Leishmania donovani that is prevalent in underdeveloped nations …

Leishmaniases and Chagas disease pose significant health challenges, particularly in
tropical regions among impoverished communities. These conditions prevail in areas …